Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects: Diurnal responses and nocturnal regulatory mechanisms

Archives of General Psychiatry

Volumn 54, Issue 4, 1997, Pages 375-385

  Schwartz, Paul J ^a   Murphy, Dennis L ^a   Wehr, Thomas A ^a   Garcia Borreguero, Diego ^a   Oren, Dan A ^a   Moul, Douglas E ^a   Ozaki, Norio ^a   Snelbaker, Alisa J ^a   Rosenthal, Norman E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; NORADRENALIN; PLACEBO; PROLACTIN;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORADRENALIN BLOOD LEVEL; PHOTOTHERAPY; PROLACTIN BLOOD LEVEL;

EID: 0030986977     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830160103013     Document Type: Article

References (84)

1. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41:72-80.
2. Rosenthal NE, Sack DA, Skwerer RG, Jacobsen FM, Wehr TA. Phototherapy for seasonal affective disorder. J Biol Rhythms. 1988;3:101-120.
3. Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B. Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology. 1989;2:1-22.
4. Jouvet M. Biogenic amines and the states of sleep. Science. 1969;163:32-41.
5. Fernstrom JD, Wurtman RJ. Brain serotonin content, increase following ingestion of a carbohydrate diet. Science. 1972;174:1023-1025.
6. Carlsson P, Svennerholm L, Winblad B. Seasonal and circadian monoamine variations in human brains examined post-mortem. Acta Psychiatr Scand. 1980; 61(suppl 280):75-82.
7. Cagampang FR, Inouye ST. Diurnal and circadian changes of serotonin in the suprachiasmatic nuclei: regulation by light and an endogenous pacemaker. Brain Res. 1994;639:175-179.
8. Wurtman RJ, Wurtman JJ. Carbohydrates and depression. Sci Am. 1989;260: 68-75.
9. Rosenthal N, Genhart M, Caballero B, Jacobsen F, Skwerer R, Coursey R, Rogers S, Spring B. Psychobiological effects of carbohydrate- and protein-rich meals in patients with seasonal affective disorder and normal controls. Biol Psychiatry. 1989;25:1029-1040.
10. O'Rourke D, Wurtman JJ, Wurtman RJ, Chebli R, Gleason R. Treatment of seasonal depression with d-fenfluramine. J Clin Psychiatry. 1989;50:343-347.
11. Lam RW, Gorman C, Michalon M, Steiner M, Levitt AJ. A multicentre, placebo-controlled study of fluoxetine in seasonal affective disorder. In: Program and abstracts of the annual meeting of the Society for Light Treatment and Biological Rhythms; June 1994:5; Bethesda, Md.
12. Neumeister A, Rieder N, Hesselmann B, Rao M-L, Gluck J, Kasper S. Serotonin function and mechanism of action of light therapy. In: Program and abstracts of the annual meeting of the Society for Light Treatment and Biological Rhythms; June 1995:7; Frankfort, Ky.
13. Lam RW, Zis AP, Grewal AK, Delgado PG, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53:41-44.
14. Kahn RS, Wetzler S. m-chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry. 1991;30:1139-1166.
15. Murphy DL, Lesch KP, Aulakh CS, Pigott TA. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev. 1991;43:527-552.
16. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Rev. 1994;46: 157-203.
17. Hamik A, Peroutka SJ. 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry. 1989;25:569-575.
18. Mueller EA, Sunderland T, Murphy DL. Neuroendocrine effects of m-CPP, a serotonin agonist, in humans. J Clin Endocrinol Metab. 1985;61:1179-1184.
19. Mueller EA, Murphy DL, Sunderland T. Further studies of the putative serotonin agonist, m-CPP: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology. 1986;89:388-391.
20. Zohar J, Mueller EA, Insel TR, Zohar-Kadouich RC, Murphy DL. Serotonergic responsivity in obsessive-compulsive disorder, comparison of patients and healthy controls. Arch Gen Psychiatry. 1987;44:946-951.
21. Lawlor BA, Sunderland T, Mellow AM, Hill JL, Newhouse PA, Murphy DL. A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects. Biol Psychiatry. 1989;25:679-686.
22. Aloi JA, Insel TR, Mueller EA, Murphy DL. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sci. 1984;34:1325-1331.
23. Maj J, Lewandowska A. Central serotoninmimetic action of phenylpiperazine. Pol J Pharmacol. 1980;32:495-504.
24. Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Murphy DL. Evidence that m-CPP-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology. 1996;123:333-339.
25. Jacobsen FM, Mueller EA, Rosenthal NE, Rogers S, Hill JL, Murphy DL. Behavioral responses to intravenous mete-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy. Psychiatry Res. 1994;52:181-197.
26. Joseph-Vanderpool JR, Jacobsen F, Murphy DL, Hill JL, Rosenthal NE. Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls. Biol Psychiatry. 1993;33:496-504.
27. van Kammen DP, Murphy DL. Attenuation of the euphoriant and activation effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia. 1975;44:215-244.
28. Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology. 1989;98:275-282.
29. Joseph-Vanderpool JR, Rosenthal NE, Chrousos GP, Wehr TA, Skwerer R, Kasper S, Gold P. Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. J Clin Endocrinol Metab. 1991;72:1382-1387.
30. Rosenthal NE, Levendosky AA, Skwerer RG, Joseph-Vanderpool JR, Kelly KA, Hardin T, Kasper S, DellaBella P, Wehr TA. Effects of light treatment on core body temperature in seasonal affective disorder. Biol Psychiatry. 1990;27:39-50.
31. Jacobsen FM, Murphy DL, Rosenthal NE. The role of serotonin in seasonal affective disorder and the antidepressant response to phototherapy. In: Rosenthal NE, Blehar MC, eds. Seasonal Affective Disorders and Phototherapy. New York, NY: Guilford Press; 1989.
32. Duncan WC, Johnson KA, Wehr TA. Antidepressant drug-induced hypothalamic cooling in Syrian hamsters. Neuropsychopharmacology. 1995;12:17-37.
33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;12:56-62.
34. Williams JBW, Link MJ, Rosenthal NE, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale-Seasonal Affective Disorders Version (SIGH-SAD). New York, NY: New York State Psychiatric Institute: 1988.
35. Brewerton TD, Murphy DL, Mueller EA, Jimerson DC. Induction of migraine-like headaches by the serotonin agonist m-CPP. Clin Pharmacol Ther. 1988; 43:605-609.
36. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM-III-R patient edition (SCID-P, 9/1/89 version). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1989.
37. White A, Smith H, Hoadley M, Dobson SH, Ratcliffe JG. Clinical evaluation of a two-site immunoradiometric assay for adrenocorticotropin in unextracted human plasma using monoclonal antibodies. Clin Endocrinol (Oxf). 1987;26:41-51.
38. Abraham GE, Buster JE, Teller RC. Radioimmunoassay of plasma cortisol. Anal Lett. 1972;5:757-766.
39. Sinha YN, Selby FW, Lewis UJ, Vanderlaan WP. A homologous radioimmunoassay for prolactin. J Clin Endocrinol Metab. 1973;36:509-516.
40. Odell WD, Rayford PL, Ross GT. Simple partially automated method for radioimmunoassay of human thyroid stimulating, growth, luteinizing and follicle stimulating hormones. J Lab Clin Med. 1967;70:973-980.
41. Schwartz PJ, Wehr TA, Rosenthal NE, Bartko JJ, Oren DA, Luetke C, Murphy DL. Serotonin and thermoregulation: physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects. Neuropsychopharmacology. 1995;13:105-115.
42. Christensen SE, Jorgensen O, Moller J, Moller N, Orskov H. Characterization of growth hormone release in response to external heating: comparison to exercise-induced release. Acta Endocrinol. 1984;107:295-301.
43. Christensen SE, Jorgensen O, Moller J, Moller N, Orskov H. Body temperature elevation, exercise and serum prolactin concentrations. Acta Endocrinol. 1985; 109:458-462.
44. Brisson GR, Audet A, Ledoux M, Matton P, Pellerin-Massicotte J, Peronnet F. Exercise-induced blood prolactin variations in trained adult males: a thermic stress more than an osmotic stress. Horm Res. 1986;23:200-206.
45. Saini J, Brandenberger G, Libert JP, Follenius M. Nocturnal pituitary hormone and renin profiles during chronic heat exposure. J Appl Physiol. 1993;75:294-300.
46. Press SJ. Generalized multivariate regression. In: Overall JE, Klett CJ, eds. Applied Multivariate Analysis. New York, NY: Holt, Rinehart, and Winston; 1972: 219-227.
47. Calogero AE, Gallucci WT, Chrousos GP, Gold PW. Effect of the catecholamines upon rat hypothalamic corticotropin releasing hormone secretion in vitro: clinical implications. J Clin Invest. 1988;82:839-846.
48. Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 1990;126:1888-1894.
49. Calogero AE, Bagdy G, Moncada ML, D'Agata R. Effect of selective serotonin agonists on basal, corticotropin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. J Endocrinol. 1993;136:381-387.
50. Fuller RW. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol. 1992;13:250-270.
51. Jacobsen F, Sack D, Wehr T, Rogers S, Rosenthal N. Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder. Arch Gen Psychiatry. 1987;44:1086-1091.
52. Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE. Hormonal responses to the administration of m-CPP in patients with seasonal affective disorder and controls. Biol Psychiatry. 1995; 37:740-749.
53. Segal M. Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J Physiol (Lond). 1979; 286:401-405.
54. al-Damluji S. Adrenergic mechanisms in the control of corticotropin secretion. J Endocrinol. 1988;119:5-14.
55. Bagdy G, Szemeredi K, Hill JK, Murphy DL. The serotonin agonist, m-CPP, markedly increases levels of plasma catecholamines in the conscious rat. Neuropharmacology. 1988;27:975-980.
56. Chrousos GP, Gold PW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 1992;267:1244-1252.
57. Swanson LW, Sawchenko PE. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology. 1980; 31:410-417.
58. Sotsky SM, Lake CR, Goodwin FK. Adrenocortical function and plasma norepinephrine in normal human subjects. Biol Psychiatry. 1981;16:643-651.
59. Skwerer RG, Jacobsen FM, Duncan CC, Kelly KA, Sack DA, Tamarkin L, Gaist PA, Rosenthal NE. Neurobiology of seasonal affective disorder and phototherapy. In: Rosenthal N, Blehar M, eds. Seasonal Affective Disorders and Phototherapy. New York, NY: Guilford Press; 1989:135-154.
60. Anderson JL, Vasile RG, Mooney JJ, Bloomingdale KL, Samson JA, Schildkraut JJ. Changes in norepinephrine output following light therapy for fall/ winter seasonal depression. Biol Psychiatry. 1992;32:700-704.
61. Rudorfer MV, Skwerer RG, Rosenthal NE. Biogenic amines in seasonal affective disorder: effects of light therapy. Psychiatry Res. 1993;46:19-28.
62. Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G. Twenty-four hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry. 1988;145:1133-1137.
63. Avery DH, Wildschiodtz G, Rafaelsen OJ. Nocturnal temperature in affective disorder. J Affect Disord. 1982;4:61-71.
64. Smallwood RG, Avery DH, Pascualy RA, Prinz PN. Circadian temperature rhythms in primary depression. Sleep Res. 1983;12:215.
65. Lund R, Kammerloher A, Dirlich G. Body temperature in endogenously depressed patients during depression and remission. In: Wehr TA, Goodwin FK, eds. Circadian Rhythms in Psychiatry. Pacific Grove, Calif: Boxwood Press; 1983:77-88.
66. Von Zerssen D, Barthelmes H, Dirlich G, Doerr P, Emrich HM, Von Lindern L, Lund R, Pirke KM. Circadian rhythms in endogenous depression. Psychiatry Res. 1985;16:51-63.
67. Czeisler CA, Kronauer RE, Mooney JJ, Anderson JL, Allan JS. Biologic rhythm disorders, depression, and phototherapy. Psychiatr Clin North Am. 1987:687-709.
68. Schwartz PJ, Rosenthal NE, Turner ET, Drake CD, Wehr TA. Abnormal seasonal variation in core temperature during sleep in patients with winter-seasonal affective disorder (SAD). Biol Psychiatry. In press.
69. Hammel HT. Temperature regulation and hibernation. In: Fisher KC, ed. Mammalian Hibernation. London, England: Oliver and Boyd; 1967:86-94.
70. Aschoff J, Pohl H. Rhythmic variations in energy metabolism. Federation Proc. 1970;29:1541-1552.
71. Heller HC, Colliver GW. CNS regulation of body temperature during hibernation. Am J Physiol. 1974;227:583-589.
72. Berger RJ, Phillips NH. Comparative aspects of energy metabolism, body temperature and sleep. Acta Physiol Scand. 1988;133:21-27.
73. Daan S, Masman D, Strijkstra A, Verhulst S. Intraspecific allometry of basal metabolic rate: relations with body size, temperature, composition, and circadian phase in the Kestrel, Falco tinnunculus. J Biol Rhythms. 1989;4:267-283.
74. Sawchenko PE, Swanson LW, Steinbusch HWM, Verhofstad AAJ. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 1983;277:355-360.
75. Matsumura K, Nakayama T, Ishikawa Y. Effects of preoptic thermal stimulation on electrical activities of neurosecretory cells in paraventricular and periventricular nuclei of the hypothalamus. Brain Res. 1983;289:330-333.
76. 2-adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-hooded rat strain relative to the Wistar rat strain. J Pharmacol Exp Ther. 1992;262:1038-1043.
77. Aulakh CS, Tolliver T, Wozniak KM, Hill JL, Murphy DL. Functional and biochemical evidence for altered serotonergic function in the fawn-hooded rat strain. Pharmacol Biochem Behav. 1994;49:615-620.
78. Ben-Jonathan N, Arbogast LA, Hyde JF. Neuroendocrine regulation of prolactin release. Prog Neurobiol. 1989;33:399-447.
79. Martin JB, Millard WJ. Brain regulation of growth hormone secretion. JAnim Sci. 1986;63(suppl 2):11.
80. Mounier F, Bluet-Pajot MT, Durand D, Kordon C, Epelbaum J. Alpha-1-noradrenergic inhibition of growth hormone secretion is mediated through the paraventricular hypothalamic nucleus in male rats. Neuroendocrinology. 1994; 59:29-34.
81. Sawchenko PE, Swanson LW, Rivier J, Vale WW. The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF. J Comp Neurol. 1985;237:100-115.
82. Juul A, Main K, Nielsen B, Skakkebaek NE. Decreased sweating in growth hormone deficiency: does it play a role in thermoregulation? J Pediatr Endocrinol. 1993;6:39-44.
83. Wehr TA, Rosenthal NE. Seasonality and affective illness. Am J Psychiatry. 1989;146:829-840.
84. Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and Circadian phase-shifting effects of light. Science. 1987;235:352-354.